Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AntibioCor: Amoxicillin + Clavulanic Acid in Severe Alcoholic Hepatitis
NCT02281929Phase 3Completed
- Sponsor
- CHU de Lille
- Start
- Jun 2015
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of amoxicillin + clavulanate in alcoholic hepatitis (AH), sponsored by CHU de Lille. Started Jun 2015; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT02281929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02281929.